CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome
Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, Cesar Luna-Rivero, Erika Mariana Hernández-Montiel, Luis Alejandro Fernández-López, María Fernanda Cabrera-Cornejo, Eduardo Misael Choreño-Parra, Alfredo Cruz-Lagunas, Andrea Domínguez, Eduardo Márquez-García, Carlos Cabello-Gutiérrez, Francina Valezka Bolaños-Morales, Lourdes Mena-Hernández, Diego Delgado-Zaldivar, Daniel Rebolledo-García, Parménides Guadarrama-OrtizNora E. Regino-Zamarripa, Criselda Mendoza-Milla, Ethel A. García-Latorre, Tatiana Sofia Rodiguez-Reyna, Diana Cervántes-Rosete, Carmen M. Hernández-Cárdenas, Shabaana A. Khader, Albert Zlotnik, Joaquín Zúñiga
Dive into the research topics of 'CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome'. Together they form a unique fingerprint.